cro.directory
← Compare landing

Cardiomedex vs NEPHRIX Biosolutions

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCardiomedexNEPHRIX Biosolutions
SummaryCardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications.Specialized preclinical CRO offering in vitro and in vivo kidney disease models, histology services, and biomarker analysis for renal and fibrotic disease drug development.
Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Translational Research
  • Cardiovascular & Metabolic Specialty Services
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Biomarker Assays
  • Pathology & Histology Services
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Metabolic
  • Cardiovascular
  • Rare Disease
  • Nephrology
Phases
  • Preclinical (General)
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Toulouse, France
  • Headquarters, Labège, Occitanie, France
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Cardiomedex alternatives · NEPHRIX Biosolutions alternatives

Markdown mirror: /compare/cardiomedex/nephrix-biosolutions.md